VANRAFIA™ is prescribed for adults with a kidney disease called primary immunoglobulin A nephropathy (IgAN). This disease can damage the kidneys and lead to faster loss of kidney function. Doctors use VANRAFIA to lower the amount of protein in the urine (proteinuria), which is a sign of kidney damage. It was approved on April 2, 2025




